DK0845475T3 - Inositolglycaner med insulinagtig virkning - Google Patents

Inositolglycaner med insulinagtig virkning

Info

Publication number
DK0845475T3
DK0845475T3 DK97119835T DK97119835T DK0845475T3 DK 0845475 T3 DK0845475 T3 DK 0845475T3 DK 97119835 T DK97119835 T DK 97119835T DK 97119835 T DK97119835 T DK 97119835T DK 0845475 T3 DK0845475 T3 DK 0845475T3
Authority
DK
Denmark
Prior art keywords
insulin
action
inositol glycans
glycans
inositol
Prior art date
Application number
DK97119835T
Other languages
Danish (da)
English (en)
Inventor
Wendelin Dr Frick
Guenter Dr Mueller
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0845475T3 publication Critical patent/DK0845475T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97119835T 1996-11-28 1997-11-13 Inositolglycaner med insulinagtig virkning DK0845475T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19649350A DE19649350A1 (de) 1996-11-28 1996-11-28 Inositolglykane mit insulinartiger Wirkung
EP97119835A EP0845475B1 (de) 1996-11-28 1997-11-13 Inositolglykane mit insulinartiger Wirkung

Publications (1)

Publication Number Publication Date
DK0845475T3 true DK0845475T3 (da) 2005-06-27

Family

ID=7813041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97119835T DK0845475T3 (da) 1996-11-28 1997-11-13 Inositolglycaner med insulinagtig virkning

Country Status (19)

Country Link
US (1) US6004938A (pl)
EP (1) EP0845475B1 (pl)
JP (1) JP4299378B2 (pl)
CN (1) CN1136224C (pl)
AR (1) AR018246A1 (pl)
AT (1) ATE290541T1 (pl)
AU (1) AU728637B2 (pl)
BR (1) BR9706041C1 (pl)
CA (1) CA2222103C (pl)
CZ (1) CZ294886B6 (pl)
DE (2) DE19649350A1 (pl)
DK (1) DK0845475T3 (pl)
ES (1) ES2237784T3 (pl)
HK (1) HK1008786A1 (pl)
HU (1) HUP9702242A3 (pl)
PL (1) PL188604B1 (pl)
PT (1) PT845475E (pl)
RU (1) RU2178794C2 (pl)
TR (1) TR199701432A2 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7312196B2 (en) * 1997-01-08 2007-12-25 Amylin Pharmaceuticals, Inc. Formulations for amylin agonist peptides
GB9814039D0 (en) * 1998-06-29 1998-08-26 Univ London Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
EP1409501B1 (en) * 2000-05-12 2008-03-05 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
AU6042601A (en) * 2000-05-12 2001-11-20 Rodaris Pharmaceuticals Limited Compounds and their uses
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
WO2001085745A1 (en) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Inositol phosphoglycan derivatives and their medical uses
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
GB0015627D0 (en) * 2000-06-26 2000-08-16 Rademacher Group Limited Phosphoglycan messengers and their medical uses
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
US7084115B2 (en) 2002-04-29 2006-08-01 Oxyplus, Inc. Inositol pyrophosphates, and methods of use thereof
AU2003248927A1 (en) * 2002-07-10 2004-01-23 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
CN100369610C (zh) * 2002-10-09 2008-02-20 中国药科大学 一种防治糖尿病的植物提取物及其制备方法与药物用途
US20070135389A1 (en) * 2004-07-06 2007-06-14 Claude Nicolau Tumor eradication by inositol-tripyrophosphate
US7745423B2 (en) * 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
WO2008080064A1 (en) * 2006-12-21 2008-07-03 Trustees Of Tufts College Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders
JP2010514772A (ja) * 2006-12-29 2010-05-06 ノームオクシス インコーポレイテッド シクリトールおよびその誘導体ならびにその治療用途
WO2008134082A1 (en) * 2007-05-01 2008-11-06 Oxyplus, Inc. Erythropoietin complementation or replacement

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446064A (en) * 1980-12-19 1984-05-01 The University Of Virginia Alumni Patents Foundation Insulin mediator substance
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4906468A (en) * 1986-04-11 1990-03-06 The Rockefeller University Insulin activity messengers, their antibodies, and thereof
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
EP0545198B1 (de) * 1991-11-29 1999-09-15 Hoechst Aktiengesellschaft Peptide mit insulinartiger Wirkung
JPH06293790A (ja) * 1993-04-08 1994-10-21 Kyowa Hakko Kogyo Co Ltd 生理活性物質イノシトールグリカン
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances

Also Published As

Publication number Publication date
DE19649350A1 (de) 1998-06-04
CN1184112A (zh) 1998-06-10
CZ377597A3 (cs) 1998-06-17
TR199701432A2 (xx) 1998-06-22
EP0845475A1 (de) 1998-06-03
AR018246A1 (es) 2001-11-14
HU9702242D0 (en) 1998-03-02
MX9709207A (es) 1998-05-31
BR9706041A (pt) 1999-11-23
CA2222103C (en) 2007-08-28
CA2222103A1 (en) 1998-05-28
DE59712220D1 (de) 2005-04-14
RU2178794C2 (ru) 2002-01-27
JPH10158291A (ja) 1998-06-16
CN1136224C (zh) 2004-01-28
PL323407A1 (en) 1998-06-08
US6004938A (en) 1999-12-21
CZ294886B6 (cs) 2005-04-13
AU4538297A (en) 1998-06-04
PT845475E (pt) 2005-06-30
PL188604B1 (pl) 2005-03-31
AU728637B2 (en) 2001-01-11
ES2237784T3 (es) 2005-08-01
HUP9702242A3 (en) 1999-01-28
HK1008786A1 (en) 1999-05-21
EP0845475B1 (de) 2005-03-09
BR9706041C1 (pt) 2000-06-06
JP4299378B2 (ja) 2009-07-22
HUP9702242A1 (hu) 1998-12-28
ATE290541T1 (de) 2005-03-15

Similar Documents

Publication Publication Date Title
DK0845475T3 (da) Inositolglycaner med insulinagtig virkning
NO971041D0 (no) Brönn-frakoplingsverktöy
ATA203196A (de) Bauelement
DE69535069D1 (de) Vermittlungseinrichtung
DE69534718D1 (de) Substituierte 9-alkyladenine
DE69523354T2 (de) Multiplexer
DE59701655D1 (de) Bauelement
DE59506221D1 (de) Gefriergerät
DE69534544D1 (de) Vermittlungseinrichtung
DK0923562T3 (da) Substituerede p-trifluormethylphenyluraciler
DE59707428D1 (de) Substituierte 1-methyl-3-benzyluracile
ATE275146T1 (de) Substituierte pyrazol-3-ylbenzazole
BR9509559A (pt) Azolilulsolfonilfeniluracilas substituídas
ID17798A (id) Pesawat kamera
ATA124098A (de) Bauteil
DE59502643D1 (de) Gefrierschrank
DE59712222D1 (de) Substituierte phenyluracile
DE59708674D1 (de) Substituierte 3-phenylpyrazole
DE69517825D1 (de) Bauelement
KR970060741U (ko) 압봉
AT362U1 (de) Skikoffer
KR950024015U (ko) 자화찬기
FI961372A0 (fi) Rissakatkoja
NO940508D0 (no) Is-fiske-SAK
KR950022661U (ko) 분리형 떡시루